AnPac Bio-Medical Science Co., Ltd. Interest Expense 2011-2026 | ANPC

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense AnPac Bio-Medical Science Co., Ltd.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
236 K	238 K	728 K	2.61 M	925 K	-	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
2.61 M	236 K	947 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	2.2 M	$ 8.97	2.87 %	$ 88.7 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.66	-	$ 8.81 B	Australia
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Anavex Life Sciences Corp. AVXL	4.68 M	$ 3.21	3.05 %	$ 274 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Brainstorm Cell Therapeutics BCLI	-93 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
BeiGene, Ltd. BGNE	-42.6 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA
BioNTech SE BNTX	14.2 M	$ 95.59	-1.15 %	$ 27.2 B	Germany
Cabaletta Bio CABA	2 M	$ 3.27	2.19 %	$ 329 M	USA
Amphastar Pharmaceuticals AMPH	23 K	$ 21.46	0.47 %	$ 1 B	USA
Checkpoint Therapeutics CKPT	344 K	-	-	$ 169 M	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	58 K	$ 1.49	1.35 %	$ 383 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 3.03	3.77 %	$ 4.99 M	Israel
Aquestive Therapeutics AQST	6.55 M	$ 4.19	-	$ 448 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 24.98	3.55 %	$ 3.18 B	USA
Chimerix CMRX	11 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	-309 K	-	-	$ 401 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	927 K	$ 32.74	0.46 %	$ 2.17 B	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.48	0.46 %	$ 394 M	Britain
Cidara Therapeutics CDTX	5.81 M	-	-	$ 1.41 B	USA
CNS Pharmaceuticals CNSP	7.03 K	$ 2.44	-2.99 %	$ 1.08 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
CTI BioPharma Corp. CTIC	13.1 M	-	-	$ 1.2 B	USA